These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

751 related items for PubMed ID: 26250934

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
    Chen L, Yao Y, Sun L, Zhou J, Miao M, Luo S, Deng G, Li J, Wang J, Tang J.
    Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
    [Abstract] [Full Text] [Related]

  • 4. Correlation of CD44v6 expression with ovarian cancer progression and recurrence.
    Shi J, Zhou Z, Di W, Li N.
    BMC Cancer; 2013 Apr 08; 13():182. PubMed ID: 23565736
    [Abstract] [Full Text] [Related]

  • 5. Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells.
    Nakamura K, Sawada K, Kinose Y, Yoshimura A, Toda A, Nakatsuka E, Hashimoto K, Mabuchi S, Morishige KI, Kurachi H, Lengyel E, Kimura T.
    Mol Cancer Res; 2017 Jan 08; 15(1):78-92. PubMed ID: 27758876
    [Abstract] [Full Text] [Related]

  • 6. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S, Guo Y, Wang Q, Li L, Wang J.
    Arch Dermatol Res; 2013 Jan 08; 305(1):35-47. PubMed ID: 22740085
    [Abstract] [Full Text] [Related]

  • 7. Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer.
    Gao Y, Foster R, Yang X, Feng Y, Shen JK, Mankin HJ, Hornicek FJ, Amiji MM, Duan Z.
    Oncotarget; 2015 Apr 20; 6(11):9313-26. PubMed ID: 25823654
    [Abstract] [Full Text] [Related]

  • 8. CD44 as a cancer stem cell marker and its prognostic value in patients with ovarian carcinoma.
    Bartakova A, Michalova K, Presl J, Vlasak P, Kostun J, Bouda J.
    J Obstet Gynaecol; 2018 Jan 20; 38(1):110-114. PubMed ID: 28816557
    [Abstract] [Full Text] [Related]

  • 9. The impact of EpCAM expression on response to chemotherapy and clinical outcomes in patients with epithelial ovarian cancer.
    Tayama S, Motohara T, Narantuya D, Li C, Fujimoto K, Sakaguchi I, Tashiro H, Saya H, Nagano O, Katabuchi H.
    Oncotarget; 2017 Jul 04; 8(27):44312-44325. PubMed ID: 28574829
    [Abstract] [Full Text] [Related]

  • 10. Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial-mesenchymal transition of the peritoneum.
    Nakamura M, Ono YJ, Kanemura M, Tanaka T, Hayashi M, Terai Y, Ohmichi M.
    Gynecol Oncol; 2015 Nov 04; 139(2):345-54. PubMed ID: 26335595
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical relevance of CD44 surface expression in advanced stage serous epithelial ovarian cancer: a prospective study.
    Elzarkaa AA, Sabaa BE, Abdelkhalik D, Mansour H, Melis M, Shaalan W, Farouk M, Malik E, Soliman AA.
    J Cancer Res Clin Oncol; 2016 May 04; 142(5):949-58. PubMed ID: 26762850
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells.
    Bhattacharya R, Mitra T, Ray Chaudhuri S, Roy SS.
    J Cell Biochem; 2018 Apr 04; 119(4):3373-3383. PubMed ID: 29130517
    [Abstract] [Full Text] [Related]

  • 16. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
    Leng Z, Xia Q, Chen J, Li Y, Xu J, Zhao E, Zheng H, Ai W, Dong J.
    Cell Physiol Biochem; 2018 Apr 04; 46(2):860-872. PubMed ID: 29627827
    [Abstract] [Full Text] [Related]

  • 17. The homeoprotein DLX4 stimulates NF-κB activation and CD44-mediated tumor-mesothelial cell interactions in ovarian cancer.
    Haria D, Trinh BQ, Ko SY, Barengo N, Liu J, Naora H.
    Am J Pathol; 2015 Aug 04; 185(8):2298-308. PubMed ID: 26067154
    [Abstract] [Full Text] [Related]

  • 18. Transformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftment.
    Jiang H, Lin X, Liu Y, Gong W, Ma X, Yu Y, Xie Y, Sun X, Feng Y, Janzen V, Chen T.
    Mol Med; 2012 Oct 24; 18(1):1197-208. PubMed ID: 22801793
    [Abstract] [Full Text] [Related]

  • 19. α2,3-sialyltransferase type I regulates migration and peritoneal dissemination of ovarian cancer cells.
    Wen KC, Sung PL, Hsieh SL, Chou YT, Lee OK, Wu CW, Wang PH.
    Oncotarget; 2017 Apr 25; 8(17):29013-29027. PubMed ID: 28423672
    [Abstract] [Full Text] [Related]

  • 20. [Clinical significance of CD44 expression in ovarian epithelial tumors].
    Qu P, Jiao S, Gao Q.
    Zhonghua Zhong Liu Za Zhi; 2001 Jan 25; 23(1):46-9. PubMed ID: 11783069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.